New prostate cancer study aims to cut fatigue and tailor treatment

NCT ID NCT06274047

First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 33 times

Summary

This study is for men with prostate cancer who have detectable PSA levels after prostate removal surgery. It tests a personalized approach using the drug apalutamide alongside radiation therapy to see if it can reduce fatigue and other side effects compared to standard care. The goal is to match treatment intensity to how aggressive the cancer is, improving quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dana-Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact Email: •••••@•••••

    Contact

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

    Contact Email: •••••@•••••

    Contact

  • Rush MD Anderson

    RECRUITING

    Chicago, Illinois, 60607, United States

    Contact Email: •••••@•••••

    Contact

  • University of Kansas Medical Center

    RECRUITING

    Kansas City, Kansas, 66103, United States

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.